A case of abiraterone acetate withdrawal syndrome after initiation of upfront abiraterone therapy for high-risk prostate cancer.

Masaru TaniYujiro HayashiAiri MikiTeppei WakitaYuki HoribeYoichi KakutaKoichi TsutaharaTetsuya Takao

Published in: IJU case reports (2023)

Abiraterone acetate withdrawal syndrome was observed when hormone-sensitive prostate cancer with upfront abiraterone therapy progressed to castration-resistant prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
case report
stem cells
mesenchymal stem cells
bone marrow